Compare PLXS & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLXS | MMSI |
|---|---|---|
| Founded | 1979 | 1987 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Electrical Products | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 4.9B |
| IPO Year | N/A | N/A |
| Metric | PLXS | MMSI |
|---|---|---|
| Price | $196.67 | $82.21 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 9 |
| Target Price | ★ $194.00 | $106.22 |
| AVG Volume (30 Days) | 426.4K | ★ 590.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $14.26 | $13.67 |
| Revenue Next Year | $8.18 | $6.16 |
| P/E Ratio | ★ $30.46 | $41.80 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $103.43 | $77.62 |
| 52 Week High | $211.84 | $109.79 |
| Indicator | PLXS | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 58.04 | 49.70 |
| Support Level | $193.49 | $77.62 |
| Resistance Level | $211.84 | $82.28 |
| Average True Range (ATR) | 10.07 | 2.27 |
| MACD | -1.15 | 0.27 |
| Stochastic Oscillator | 60.44 | 86.42 |
Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.